Arrhythmias/Electrophysiology
Cohort Study | Visit-to-visit SBP variability linked to increased risk of atrial fibrillation in middle-aged and older populations.
17 Oct, 2022 | 12:30h | UTC
Case series and systematic review | Life-threatening cardiac arrhythmia and sudden death during electronic gaming.
13 Oct, 2022 | 13:49h | UTCEditorial: Ventricular arrhythmias during electronic gaming: Sudden victory and sudden death – Heart Rhythm
News Release: Electronic gaming can trigger potentially lethal heart rhythm problems in susceptible children – Elsevier
Expert Consensus | Screening, diagnosis and follow-up of Brugada syndrome in children.
13 Oct, 2022 | 13:47h | UTC
Brief Review | Atrial fibrillation: rate control or rhythm control?
5 Oct, 2022 | 13:50h | UTCAtrial fibrillation: Rate control or rhythm control? – Cleveland Clinic Journal of Medicine
Evaluation of an ambulatory ECG analysis platform using deep neural networks in routine clinical practice.
20 Sep, 2022 | 13:14h | UTC
Commentary on Twitter
An AI-based Holter ECG analysis strategy saves time and performs similarly compared with a conventional approach @EloiMarijon #AHAJournals https://t.co/lK7h0po4xj
— JAHA (@JAHA_AHA) September 15, 2022
AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.
16 Sep, 2022 | 13:00h | UTC
Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation: a registry-based randomized controlled noninferiority study.
8 Sep, 2022 | 14:46h | UTCEarly Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study – Circulation (free for a limited period)
Commentary on Twitter
Congrats to my good friend/colleague @BoNorrving for the TIMING study! Starting NOAC after stroke d/t AF <4 d is safe (no ICH) and = or better than 5-10 d. Registry-based, pragmatic, investigator led, PROBE design. High value = science first approach.
https://t.co/35qiZ5Ivoa— Dr. Lee Schwamm (@Braindoc_MGH) September 7, 2022
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.
7 Sep, 2022 | 12:30h | UTC
Commentary on Twitter (thread – click for more)
AF associated with ⬆️ risk of cognitive impairment 👉
📌 HR 1.39 general 👫
📌 HR 2.70 post-stroke 👫@natale_md @TJaredBunch @Dr_Santangeli @JonPicciniSr @DrMarthaGulati @rafavidalperez @DhirajGuptaBHRS @SABOURETCardio @iamritu @Hragy @mmamas1973 @SeguraCardio @cpgale3 #afib pic.twitter.com/dZxkd7G1wc— Raviele Antonio (@drraviele) January 21, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.
5 Sep, 2022 | 14:33h | UTCHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
#ESCCongress – RCT | In patients with rheumatic heart disease–associated atrial fibrillation, treatment with a Vitamin K antagonist led to a lower rate of cardiovascular events or death compared to Rivaroxaban.
29 Aug, 2022 | 12:33h | UTCRivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Trial backs standard of care for rheumatic heart disease and atrial fibrillation – European Society of Cardiology
Commentary: INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF – TCTMD
Commentary on Twitter
INVICTUS: In patients with RHD-associated AF, compared to rivaroxaban, VKA reduced cardiovascular events and mortality without increasing bleeding. #ESCCongress https://t.co/4C45LmmB5o pic.twitter.com/9n3OelzZvp
— NEJM (@NEJM) August 28, 2022
#ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
29 Aug, 2022 | 12:21h | UTCNews Release: People of all ages should learn cardiopulmonary resuscitation – European Society of Cardiology
#ESCCongress – Single-arm study | Efficacy and safety of an extravascular implantable cardioverter–defibrillator.
29 Aug, 2022 | 12:09h | UTCEfficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
EV ICD: Extravascular ICD can be implanted safely and can detect and terminate induced ventricular arrhythmias at the time of implant. #ESCCongress https://t.co/Th9evkPcIu pic.twitter.com/qWEcM8MggT
— NEJM (@NEJM) August 28, 2022
Secondary analysis of a RCT | Early rhythm control in patients with atrial fibrillation and high comorbidity burden.
24 Aug, 2022 | 14:11h | UTCEarly Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden – Circulation
Commentary on Twitter
#OriginalResearch: In #EAST_AFNET4, substudy of patients w/ CHA2DS2VASC4 >=4 had decreased composite efficacy outcome of lower CV death, CVA or HF/ACS hospitalization w/ rhythm control, but not in patients with lower como… @AndreasRillig @AndreasMetzner7 https://t.co/izES0WodVQ pic.twitter.com/DVyfWsUsOx
— Circulation (@CircAHA) August 17, 2022
Review | Left atrial appendage occlusion, a misnomer?
22 Aug, 2022 | 12:01h | UTCLeft Atrial Appendage Occlusion, A Misnomer? – Mayo Clinic Proceedings
Review | Why is my patient still in sinus tachycardia?
17 Aug, 2022 | 14:06h | UTCWhy Is My Patient Still In Sinus Tachycardia? – emDocs
Cohort Study | Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation.
15 Aug, 2022 | 11:38h | UTCCommentary: ‘Obesity Paradox’ in Atrial Fibrillation Challenged as Mortality Climbs With BMI – Medscape (free registration required)
Commentary from the author on Twitter (thread – click for more)
🚨🚨 Really excited about our new paper out in @Open_HeartBMJ
Using the @GARFIELD_reg of newly diagnosed AF patients (n=40,482), we examine the association between height/BMI and risk of AF outcomes. https://t.co/lMDCzDsfHw@TRI_Thrombosis
— Fielder Camm (@cfcamm) August 8, 2022
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.
12 Aug, 2022 | 14:48h | UTC
Cohort Study | Age at menopause and risk of heart failure and atrial fibrillation.
5 Aug, 2022 | 14:38h | UTCAge at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study – European Heart Journal (link to abstract – $ for full-text)
Editorial: Premature menopause and cardiovascular disease: can we blame estrogen? – European Heart Journal
News Release: Premature menopause is associated with increased risk of heart problems – European Society of Cardiology
Cohort Study | Incidence, associated risk factors, and outcomes of postoperative arrhythmia after upper gastrointestinal surgery.
26 Jul, 2022 | 11:52h | UTCCommentary: Incidence and Outcomes of Postop Arrhythmia After Upper GI Surgery – American College of Cardiology
Commentary on Twitter
This cohort study of 1,210 patients undergoing upper GI surgery found new-onset postop atrial fibrillation (AF) was associated with increased in-hospital mortality, prolonged ICU stay, and development of permanent or paroxysmal AF. https://t.co/8Bxq5uGuqa
— JAMA Network Open (@JAMANetworkOpen) July 21, 2022
M-A | Utility of provocative testing in the diagnosis and genotyping of congenital long QT syndrome.
13 Jul, 2022 | 11:13h | UTC
Retrospective Cohort Study | New-onset atrial fibrillation in intensive care: epidemiology and outcomes.
13 Jul, 2022 | 11:11h | UTC
Commentary on Twitter
What are the long-term impacts of new onset AFIB in ICU patients?
RISK-II database >20,000 patients, >248 English ICUs:
– increased risk of in hospital mortality
– increased risk of readmiaaion for AFIB/HF/stroke!https://t.co/2Gec2XpwPv pic.twitter.com/ZXyiGPAtWf— EHJACVC Editor-in-Chief (@EHJACVCEiC) July 11, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ License
RCT | First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation.
11 Jul, 2022 | 12:21h | UTC
Commentary on Twitter
#OriginalResearch: In #PAUSE_SCD RCT, early first-line catheter ablation performed concurrent with ICD implantation for monomorphic VT significantly reduced the composite primary outcome of VT recurrence, CV hospitalization, or death @DrRoderickTung https://t.co/ifQvG9A4j5 pic.twitter.com/5WAcPz3Mlm
— Circulation (@CircAHA) May 5, 2022
M-A | DOACs vs. VKAs in atrial fibrillation patients with bioprosthetic heart valve.
7 Jul, 2022 | 12:15h | UTC
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
5 Jul, 2022 | 11:29h | UTCEditorial: Arrhythmogenic right ventricular cardiomyopathy: the never-ending quest for a risk calculator
Cohort Study | Novel risk prediction model to determine adverse heart failure outcomes in arrhythmogenic right ventricular cardiomyopathy.
4 Jul, 2022 | 11:53h | UTCEditorial: Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy